8A3-22271-00936
3 vaccinations
3 coded responses
22 check-ins
3 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 989 / WA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-23
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2020-12-24
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Joint painsAdult check-in
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2021-01-05
Call successfulCompleted over the phone
- 2021-01-06
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-21
- 2021-01-22
- 2021-01-30
-
2021-02-07
Survey response — day 21, dose 2MedDRA: Malaise, Myalgia, Pyrexia — Feeling: GoodFree text: I am largely doing well now. Some myalgia, low grade fever mid week. Within 12 hours of recieving the second Pfizer dose I developed symptoms very similar to having COVID the first time. I am certain the risk was known. It was not disclosed. ThatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-04-16
- 2021-07-16
- 2022-01-15
-
2022-03-18
Dose 3 — Pfizer-BioNTech
-
2022-04-19
Survey response — day 28, dose 3MedDRA: COVID-19, Deafness, Eustachian tube dysfunction, Laryngitis, Middle ear disorder, Office visit, Pharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Midde ear and eustacian tube dysfuction. I was diagnosed with COVID 1/23/22 and had significant pharyngitis/ laryngitis and middle ear dysfuction with hearing loss that has never recovered. Seen ENT. Scheduled to see neurootologistMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-22
Survey response — day 35, dose 3MedDRA: Eustachian tube dysfunction, Inner ear disorder, Laryngitis, Middle ear disorder, Office visit, Pharyngitis, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I had a possitive COVID 01/23. I had prominent laryngitis, pharangitis, eustacian tube, middle and inner ear dysfuction. These problems are persistent. Ihave seen an ENT and been referred to a neuro-otologist. I have had booster no complicationMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-22
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2022-03-18 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 1
Free text
Release 3 — day 21, dose 2
Symptoms: I am largely doing well now. Some myalgia, low grade fever mid week. Within 12 hours of recieving the second Pfizer dose I developed symptoms very similar to having COVID the first time. I am certain the risk was known. It was not disclosed. That cut off by CDC
Release 11 — day 28, dose 3
Symptoms: Midde ear and eustacian tube dysfuction. I was diagnosed with COVID 1/23/22 and had significant pharyngitis/ laryngitis and middle ear dysfuction with hearing loss that has never recovered. Seen ENT. Scheduled to see neurootologist
Release 11 — day 35, dose 3
Symptoms: I had a possitive COVID 01/23. I had prominent laryngitis, pharangitis, eustacian tube, middle and inner ear dysfuction. These problems are persistent. Ihave seen an ENT and been referred to a neuro-otologist. I have had booster no complication cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Deafness | · | · | ✓ |
| SD | Eustachian tube dysfunction | · | · | ✓ |
| SD | Inner ear disorder | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Middle ear disorder | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pharyngitis | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release